Platelet-Rich Plasma vs. Corticosteroid for Tennis Elbow: A Randomized Trial .
Platelet-rich plasma versus corticosteroid: a randomized controlled trial on tennis elbow patients resistant to nonsurgical treatments.
Ann Med Surg (Lond). 2023 Aug 3;85(9):4385-4388.30 patients with lateral epicondylitis unresponsive to conservative treatment were randomized to receive an injection of corticosteroid (n=15) or platelet-rich plasma (PRP; n=15). The primary outcomes of interest were pain measured on a Visual Analog Scale (VAS) and the Disability of the Arm, Shoulder, and Hand (DASH) score. Outcomes were measured 1 month after injection. The PRP group demonstrated significantly better improvement in both VAS pain scores and DASH scores compared to the corticosteroid group. Future studies with larger sample sizes, longer follow-up, and more comprehensive clinical assessments are required to confirm the results of this study.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
